BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10048975)

  • 21. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
    Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro.
    Fukazawa H; Li PM; Yamamoto C; Murakami Y; Mizuno S; Uehara Y
    Biochem Pharmacol; 1991 Oct; 42(9):1661-71. PubMed ID: 1656993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate Sam68 and retards subsequent exit from mitosis of Src-transformed cells.
    Pillay I; Nakano H; Sharma SV
    Cell Growth Differ; 1996 Nov; 7(11):1487-99. PubMed ID: 8930398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
    Faris M; Gaskin F; Parsons JT; Fu SM
    J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin.
    Belvedere G; Imperatori L; Damia G; Tagliabue G; Meijer C; de Vries EG; D'Incalci M
    Eur J Cancer; 1996 Oct; 32A(11):2011-8. PubMed ID: 8943689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases.
    Uehara Y; Fukazawa H
    Methods Enzymol; 1991; 201():370-9. PubMed ID: 1658554
    [No Abstract]   [Full Text] [Related]  

  • 28. Mitogen-activated protein kinase (ERK1/2) activation by shear stress and adhesion in endothelial cells. Essential role for a herbimycin-sensitive kinase.
    Takahashi M; Berk BC
    J Clin Invest; 1996 Dec; 98(11):2623-31. PubMed ID: 8958227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
    Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
    Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of protein tyrosine kinase p72syk and phosphatidylinositol 3-kinase in CD2-mediated granular exocytosis in the natural killer cell line, NK3.3.
    Umehara H; Huang JY; Kono T; Tabassam FH; Okazaki T; Bloom ET; Domae N
    J Immunol; 1997 Aug; 159(3):1200-7. PubMed ID: 9233614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells.
    Masumoto N; Nakano S; Esaki T; Fujishima H; Tatsumoto T; Niho Y
    Int J Cancer; 1995 Jul; 62(1):70-5. PubMed ID: 7601570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway.
    Yen L; Nie ZR; You XL; Richard S; Langton-Webster BC; Alaoui-Jamali MA
    Oncogene; 1997 Apr; 14(15):1827-35. PubMed ID: 9150389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different mechanisms are responsible for c-jun mRNA induction by cisplatin and ultraviolet light.
    Rabo YB; Shoshan MC; Linder S; Hansson J
    Int J Cancer; 1996 Mar; 65(6):821-6. PubMed ID: 8631598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the Ras signaling pathway by the CD40 receptor.
    Gulbins E; Brenner B; Schlottmann K; Koppenhoefer U; Linderkamp O; Coggeshall KM; Lang F
    J Immunol; 1996 Oct; 157(7):2844-50. PubMed ID: 8816388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corneal IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts.
    Natarajan K; Rajala MS; Chodosh J
    J Immunol; 2003 Jun; 170(12):6234-43. PubMed ID: 12794155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Masumoto N; Fujishima H; Niho Y
    Int J Cancer; 1996 Feb; 65(4):479-84. PubMed ID: 8621231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of phosphoinositide 3-kinase and its association with pp60src in cholecystokinin-stimulated pancreatic acinar cells.
    Nozu F; Owyang C; Tsunoda Y
    Eur J Cell Biol; 2000 Nov; 79(11):803-9. PubMed ID: 11139143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src activation regulates anoikis in human colon tumor cell lines.
    Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
    Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labeling of v-Src and BCR-ABL tyrosine kinases with [14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism.
    Fukazawa H; Uehara Y; Murakami Y; Mizuno S; Hamada M; Takeuchi T
    FEBS Lett; 1994 Mar; 340(3):155-8. PubMed ID: 8131836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.
    Kishimoto S; Miyazawa K; Terakawa Y; Ashikari H; Ohtani A; Fukushima S; Takeuchi Y
    Jpn J Cancer Res; 2000 Dec; 91(12):1326-32. PubMed ID: 11123433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.